Coronary Stents


Demonstrated exceptionally low TLR rate of 5.1% at 9 months and superior deliverability with the Flexx2 delivery system.

elunir stent.

EluNIR® Drug Eluting Stent (DES)

The EluNIR DES’s innovative engineering and unique WiZeCell™ design delivers excellent clinical outcomes with an extremely low rate of late/very late stent thrombosis (0.1%) through 24 months.